| |
| |
|
| Insider
Information: |
Evans Daron |
| Relationship: |
|
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
269,267 |
|
|
Indirect Shares
|
57,269 |
|
|
| Direct
Value |
$396,980 |
|
|
|
Indirect Value
|
$108,106 |
|
|
| Total
Shares |
326,536 |
|
|
| Total
Value |
$505,086 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 83.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Capricor Therapeutics |
CAPR |
Chief Financial Officer |
2009-07-07 |
14,152 |
2009-07-07 |
9,600 |
Premium* |
|
|
Nephros Inc |
NEPH |
CEO Specialty Renal Pr... |
2021-05-24 |
134,215 |
2021-05-27 |
8,669 |
Premium* |
|
|
Rezolute, Inc |
RZLT |
|
2024-03-15 |
120,900 |
2024-03-15 |
39,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2008-04-14 |
4 |
B |
$4.50 |
$900 |
D/D |
200 |
200 |
2.66 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2008-04-14 |
4 |
B |
$4.50 |
$2,740 |
I/I |
600 |
200 |
1.91 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2008-12-11 |
4 |
B |
$0.54 |
$440 |
I/I |
814 |
1,014 |
1.91 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2008-12-11 |
4 |
B |
$0.81 |
$2,430 |
D/D |
3,000 |
3,200 |
2.66 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2008-12-12 |
4 |
B |
$1.25 |
$1,250 |
D/D |
1,000 |
4,200 |
2.66 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2008-12-12 |
4 |
B |
$0.70 |
$2,230 |
I/I |
3,186 |
4,200 |
1.91 |
- |
|
| RZLT |
Rezolute, Inc |
CFO |
• • – |
2024-02-16 |
4 |
B |
$1.37 |
$12,330 |
I/I |
9,000 |
4,500 |
0.01 |
% |
|
| NEPH |
Nephros Inc |
Director |
– • – |
2013-11-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,500 |
|
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2019-06-14 |
4 |
B |
$0.58 |
$19,078 |
I/I |
32,000 |
8,000 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
CEO Specialty Renal Products |
• – – |
2021-05-27 |
4/A |
D |
$2.70 |
$1,885 |
I/I |
(698) |
8,669 |
0 |
- |
|
| NEPH |
Nephros Inc |
CEO of Specialty Renal Product |
• – – |
2021-05-24 |
4 |
OE |
$2.70 |
$5,999 |
I/I |
2,222 |
9,018 |
0 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2009-03-13 |
4 |
B |
$0.75 |
$3,750 |
D/D |
5,000 |
9,200 |
2.66 |
- |
|
| NEPH |
Nephros Inc |
Director |
– • – |
2014-03-21 |
4 |
A |
$0.30 |
$645 |
D/D |
2,151 |
9,651 |
0 |
- |
|
| RZLT |
Rezolute, Inc |
CFO |
• – – |
2024-01-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,000 |
|
% |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2009-03-11 |
4 |
B |
$0.77 |
$4,620 |
I/I |
6,000 |
10,200 |
1.91 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Financial Officer |
• – – |
2009-07-07 |
4 |
B |
$0.00 |
$0 |
D/D |
3,952 |
14,152 |
2.66 |
- |
|
| RZLT |
Rezolute, Inc |
CFO |
• • – |
2024-03-15 |
4 |
B |
$1.69 |
$33,830 |
I/I |
20,000 |
20,000 |
0.01 |
% |
|
| RZLT |
Rezolute, Inc |
CFO |
• – – |
2024-01-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,000 |
|
% |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-03-17 |
4 |
B |
$0.00 |
$0 |
I/I |
83,332 |
41,666 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-06-09 |
4 |
B |
$0.26 |
$4,550 |
I/I |
17,500 |
49,166 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2017-08-22 |
4 |
B |
$0.25 |
$1,000 |
I/I |
4,000 |
51,166 |
2.58 |
- |
|
| NEPH |
Nephros Inc |
Director |
– • – |
2014-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
43,194 |
52,845 |
0 |
- |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2018-04-10 |
4 |
B |
$0.45 |
$35,550 |
I/I |
79,000 |
63,166 |
2.66 |
- |
|
| RZLT |
Rezolute, Inc |
CFO |
• • – |
2024-02-16 |
4 |
B |
$1.30 |
$54,411 |
D/D |
41,900 |
70,900 |
0.01 |
% |
|
| NEPH |
Nephros Inc |
Director |
– • – |
2014-12-18 |
4 |
A |
$0.60 |
$12,743 |
D/D |
21,239 |
74,084 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
